NATCO - Sell - Short Term There is a FVG and already been tested be a tail. better go with a short for short term but be cautious.
It's educational purpose only. NOT A SIGNAL.
NATCO Pharma Limited
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
85.90 INR
18.85 B INR
44.15 B INR
86.87 M
About NATCO Pharma Limited
Sector
Industry
CEO
Rajeev Nannapaneni
Website
Headquarters
Hyderabad
Founded
1981
ISIN
INE987B01026
FIGI
BBG000F4LSP2
NATCO Pharma Ltd. engages in the business of pharmaceuticals with research, manufacturing and marketing of finished dosage formulations and active pharmaceutical ingredients. It operates through the following segments: Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients. The Domestic Formulations segment operates in the divisions of oncology, pharma specialties and CnD. The International Formulations segment exports its FDF products from India to several international geographies either through its local partners or directly through its subsidiaries such as in Canada and Brazil. The Active Pharmaceutical Ingredients segment is strategically important as it develops APIs for the captive consumption of many of NATCO's critical FDF products in addition to supplying to direct customers. The company was founded by Venkaiah Chowdary Nannapaneni in 1981 and is headquartered in Hyderabad, India.
Related stocks
BUY TODAY SELL TOMORROW for 5%DON’T HAVE TIME TO MANAGE YOUR TRADES?
- Take BTST trades at 3:25 pm every day
- Try to exit by taking 4-7% profit of each trade
- SL can also be maintained as closing below the low of the breakout candle
Now, why do I prefer BTST over swing trades? The primary reason is that I have observed that
NATCOPHARM 1 Week View📌 Key figures:
Latest price around ₹870–₹875 (approx) per share.
52-week range: Low ~ ₹726.80, High ~ ₹1,505.00.
Weekly pivot point (standard) ~ ₹832.38, weekly support ~ ₹812.22, weekly resistance ~ ₹852.12.
📊 Important weekly levels to watch:
Support around ~ ₹812–₹832 (this is the pivot zone
Natco Pharma LtdDate 13.09.2025
Natco Pharma
Timeframe : Day Chart
Business Segments
(1) Export Formulation 44%
(2) Domestic Formulation 15%
(3) Active Pharmaceutical Ingredients 10%
(4) Crop Health Sciences 2%
(5) Other 29%
Manufacturing Facilities
(1) Operates 8 manufacturing plants
(2) 05 for finished dos
buy buy buybuy natco pharma @ 852 for a target of 1100 within 3 months .For more calls like this kindly contact to the above number (paid service,,,100% accuracy)..I have many stocks which will reach a potential target upto 50 percent minimum....Contact number is 7411839705
Natco Pharma - Gap filling setup Natco Pharma - Gap filling setup
Technical Outlook
CMP : 1011
Chart Pattern
Stock had gapped down from 1189 to 1051 in Feb'25.
Since then, the stock seems to have settled down in a upward parallel channel as pointed out in the chart.
On weekly charts ,
EMA 9 is poised to crossover EMA 21, whi
NATCOPHARMANATCOPHARMA gave BO of long time resistance, looking in a good position.
Now there is probability of an upside move.
✅ If you like my analysis, please follow me as a token of appreciation :)
in.tradingview.com/u/SatpalS/
📌 For learning and educational purposes only, not a recommendation. Pleas
NATCOPHARM - Trend Reversal Strenght PatternNATCOPHARM
Looks Good for SWING TRADE
Shows trend reversal strenght pattern.
Trading near 200 daily ema.
Volume building..
NATCOPHARM - Weekly AnalysisIn the Weekly Chart of NATCOPHARM ,
we can see that; it is at decision making point.
Possible momentums are shown in chart.
Natco Pharma - Enough CorrectionCMP 875 on 22.05.25
The stock price dropped 50% between September 2024 and March 2025. In recent days, it has been consolidating near the 800 levels, which is acting as a support zone, as shown on the chart.
MACD shows a likely crossover, too.
If it gives an upside move, further targets may be 1080/
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
SMALLCAP
Mirae Asset Nifty Smallcap 250 Momentum Quality 100 ETF Units Exchange Traded FundWeight
0.71%
Market value
568.65 K
USD
TLTE
FlexShares Morningstar Emerging Markets Factor Tilt Index FundWeight
0.13%
Market value
382.15 K
USD
Explore more ETFs
Frequently Asked Questions
The current price of NATCOPHARM is 867.50 INR — it has decreased by −2.84% in the past 24 hours. Watch NATCO Pharma Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange NATCO Pharma Limited stocks are traded under the ticker NATCOPHARM.
NATCOPHARM stock has fallen by −6.82% compared to the previous week, the month change is a 7.24% rise, over the last year NATCO Pharma Limited has showed a −42.16% decrease.
We've gathered analysts' opinions on NATCO Pharma Limited future price: according to them, NATCOPHARM price has a max estimate of 1,160.00 INR and a min estimate of 712.00 INR. Watch NATCOPHARM chart and read a more detailed NATCO Pharma Limited stock forecast: see what analysts think of NATCO Pharma Limited and suggest that you do with its stocks.
NATCOPHARM reached its all-time high on Sep 12, 2024 with the price of 1,638.35 INR, and its all-time low was 7.60 INR and was reached on Oct 27, 2008. View more price dynamics on NATCOPHARM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NATCOPHARM stock is 3.81% volatile and has beta coefficient of 1.39. Track NATCO Pharma Limited stock price on the chart and check out the list of the most volatile stocks — is NATCO Pharma Limited there?
Today NATCO Pharma Limited has the market capitalization of 159.92 B, it has decreased by −3.71% over the last week.
Yes, you can track NATCO Pharma Limited financials in yearly and quarterly reports right on TradingView.
NATCO Pharma Limited is going to release the next earnings report on Feb 18, 2026. Keep track of upcoming events with our Earnings Calendar.
NATCOPHARM earnings for the last quarter are 29.00 INR per share, whereas the estimation was 24.55 INR resulting in a 18.10% surprise. The estimated earnings for the next quarter are 1.20 INR per share. See more details about NATCO Pharma Limited earnings.
NATCO Pharma Limited revenue for the last quarter amounts to 13.63 B INR, despite the estimated figure of 11.91 B INR. In the next quarter, revenue is expected to reach 5.41 B INR.
NATCOPHARM net income for the last quarter is 5.18 B INR, while the quarter before that showed 4.81 B INR of net income which accounts for 7.84% change. Track more NATCO Pharma Limited financial stats to get the full picture.
NATCO Pharma Limited dividend yield was 0.75% in 2024, and payout ratio reached 5.70%. The year before the numbers were 1.00% and 12.28% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 10, 2025, the company has 4.96 K employees. See our rating of the largest employees — is NATCO Pharma Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NATCO Pharma Limited EBITDA is 17.37 B INR, and current EBITDA margin is 50.90%. See more stats in NATCO Pharma Limited financial statements.
Like other stocks, NATCOPHARM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NATCO Pharma Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NATCO Pharma Limited technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NATCO Pharma Limited stock shows the neutral signal. See more of NATCO Pharma Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.